Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Scheinberg

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Experimental Hematology|May 27, 2006
Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineeringPhillip Scheinberg, David A Price, David R Ambrozak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decadesJessica M Valdez, Phillip Scheinberg, Olga Nunez, et al.
The New England Journal of Medicine|August 5, 2011
Horse versus rabbit antithymocyte globulin in acquired aplastic anemiaPhillip Scheinberg, Olga Nunez, Barbara Weinstein, et al.
JAMA|September 23, 2010
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemiaPhillip Scheinberg, James N Cooper, Elaine M Sloand, et al.
Experimental Hematology|October 29, 2008
Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patientsElaine M Sloand, Loretta Pfannes, Phillip Scheinberg, et al.
Haematologica|March 9, 2010
Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumabElaine M Sloand, Matthew J Olnes, Barbara Weinstein, et al.
Haematologica|February 3, 2009
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized studyPhillip Scheinberg, Colin O Wu, Olga Nunez, et al.
American Journal of Hematology|January 14, 2014
Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemiaPhillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, et al.
Haematologica|December 10, 2009
Granulocyte transfusions in severe aplastic anemia: an eleven-year experienceKaren Quillen, Edward Wong, Phillip Scheinberg, et al.
Transfusion|May 21, 2009
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactionsJennifer Daniel-Johnson, Susan Leitman, Harvey Klein, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Experimental Hematology|May 27, 2006
Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineeringPhillip Scheinberg, David A Price, David R Ambrozak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decadesJessica M Valdez, Phillip Scheinberg, Olga Nunez, et al.
The New England Journal of Medicine|August 5, 2011
Horse versus rabbit antithymocyte globulin in acquired aplastic anemiaPhillip Scheinberg, Olga Nunez, Barbara Weinstein, et al.
JAMA|September 23, 2010
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemiaPhillip Scheinberg, James N Cooper, Elaine M Sloand, et al.
Experimental Hematology|October 29, 2008
Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patientsElaine M Sloand, Loretta Pfannes, Phillip Scheinberg, et al.
Haematologica|March 9, 2010
Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumabElaine M Sloand, Matthew J Olnes, Barbara Weinstein, et al.
Haematologica|February 3, 2009
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized studyPhillip Scheinberg, Colin O Wu, Olga Nunez, et al.
American Journal of Hematology|January 14, 2014
Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemiaPhillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, et al.
Haematologica|December 10, 2009
Granulocyte transfusions in severe aplastic anemia: an eleven-year experienceKaren Quillen, Edward Wong, Phillip Scheinberg, et al.
Transfusion|May 21, 2009
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactionsJennifer Daniel-Johnson, Susan Leitman, Harvey Klein, et al.
Pageof 13